¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ Æ©ºê ½ÃÀå º¸°í¼­(2025³â)
Biopharmaceutical Tubing Global Market Report 2025
»óǰÄÚµå : 1702959
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,339,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,163,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,987,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¹ÙÀÌ¿ÀÀǾàǰ Æ©ºê ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â±îÁö 11.3%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î 74¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº ¹ÙÀÌ¿ÀÀǾàǰ »ý»ê Áõ°¡, ±ÔÁ¦ ¹× Á¤Ã¥ °­È­, È¿À²ÀûÀÌ°í ¹«°øÇØ ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º¿¡ ´ëÇÑ ¿ä±¸ Áõ°¡, ¾ÈÀü Á¶Ä¡ Áõ°¡, ÀǾàǰ ¿¬±¸ °³¹ßÀÇ ¼ºÀå¿¡ ±âÀÎÇÏ´Â °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ÀÏȸ¿ë ½Ã½ºÅÛÀÇ ¹ßÀü, Æ©ºê ¼ÒÀçÀÇ Çõ½Å, ¸ÂÃãÇü Æ©ºê ¼Ö·ç¼ÇÀÇ ¹ßÀü, Æ©ºê ¼³°èÀÇ Çõ½Å µîÀ» µé ¼ö ÀÖ½À´Ï´Ù.

°³ÀÎ ¸ÂÃãÇü ÀÇ·áÀÇ ÀÌ¿ë È®´ë°¡ ¹ÙÀÌ¿ÀÀǾàǰ Æ©ºê ½ÃÀå È®´ë¸¦ °ßÀÎÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. °³ÀÎ ¸ÂÃãÇü ÀÇ·á´Â ÀÇ·á °áÁ¤, Áø·á, ÁßÀç, Ä¡·á¸¦ ȯÀÚ °³°³ÀÎÀÇ Æ¯¼º¿¡ ¸Â°Ô ¸ÂÃãÈ­ÇÏ´Â Á¢±Ù ¹æ½ÄÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀº À¯ÀüÀÚ ¿¬±¸ÀÇ ¹ßÀüÀ¸·Î °³ÀÎÀÇ À¯ÀüÀÚ ÇÁ·ÎÆÄÀÏ, ¶óÀÌÇÁ½ºÅ¸ÀÏ, ƯÁ¤ °Ç°­ »óÅ¿¡ ¸Â´Â Ä¡·á Àü·«ÀÌ °¡´ÉÇØÁü¿¡ µû¶ó ¸¹Àº ÁöÁö¸¦ ¹Þ°í ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿ÀÀǾàǰ Æ©ºê´Â ¸ÂÃãÇü Ä¡·á ¹× Ä¡·á¸¦ Á¦°øÇÏ´Â µ¥ ÇʼöÀûÀÎ Á¤È®ÇÏ°í ¹«±ÕÀûÀÌ¸ç ½Å·ÚÇÒ ¼ö ÀÖ´Â ÁÖÀÔÀ» º¸ÀåÇÔÀ¸·Î½á °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ ±â¹ÝÀÇ È¸¿ø ´ÜüÀÎ °³ÀθÂÃãÀǷῬÇÕ(Personalized Medicine Coalition)Àº 2022³â¿¡ »õ·Î ½ÂÀÎµÈ Ä¡·á¹ýÀÇ ¾à 34%¿¡ ÇØ´çÇÏ´Â 12°³ÀÇ °³ÀθÂÃãÇü ½Å¾àÀÌ ½ÂÀ뵃 °ÍÀ̶ó°í º¸°íÇß½À´Ï´Ù. ÀÌ´Â ÀÌÀüº¸´Ù Å©°Ô Áõ°¡ÇÑ ¼öÄ¡·Î, ¹ÙÀÌ¿ÀÀǾàǰ Æ©ºê ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇÏ´Â °³ÀθÂÃãÇü ÀÇ·áÀÇ ¿ªÇÒÀ» °­Á¶Çϰí ÀÖ½À´Ï´Ù.

¹ÙÀÌ¿ÀÀǾàǰ Æ©ºê ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷µéÀº ÷´Ü ¹ÙÀÌ¿ÀÀǾàǰ ¿ëµµÀÇ ¼º´É, ¹«±Õ¼º, À¯Ã¼ Ãë±ÞÀ» °­È­Çϱâ À§ÇØ »ýÈí¼ö¼º Æ©ºê¿Í °°Àº Â÷¼¼´ë ¼Ö·ç¼ÇÀ¸·Î Á¦Ç°À» Á¦°øÇÕ´Ï´Ù. »ýü Èí¼ö¼º Æ©ºê´Â ü³»¿¡¼­ ¼­¼­È÷ ºÐÇØ ¹× Èí¼öµÇ¾î »ç¿ë ÈÄ Á¦°ÅÇÒ Çʿ䰡 ¾ø´Â Àç·á·Î ¸¸µé¾îÁý´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 9¿ù, ¹Ì±¹¿¡ º»»ç¸¦ µÐ ÷´Ü Æú¸®¸Ó ¼Ö·ç¼Ç Á¦°ø¾÷üÀÎ Á¦¿ì½º(Zeus)´Â »ýü Èí¼ö¼º Ç÷°ü ºñ°è(BRS)¿ëÀ¸·Î ¼³°èµÈ Â÷¼¼´ë »ýü Èí¼ö¼º Á¦Ç°ÀÎ Absorv XSE ÁöÇ⼺ Æ©ºê¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ ±â¼ú Çõ½ÅÀº ÀÇ·á±â±â Á¦Á¶¾÷üµéÀÌ °ü»óµ¿¸Æ Áúȯ Ä¡·á ¿Ü¿¡µµ BRSÀÇ Àû¿ëÀ» ¸ð»öÇÒ ¼ö ÀÖ°Ô ÇØÁÖ¸ç, ´Ù¾çÇÑ ½Ã¼ú¿¡¼­ ±Ý¼Ó ½ºÅÙÆ®¸¦ ´ëüÇÒ ¼ö ÀÖ´Â °¡´É¼ºÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ »õ·Î¿î Æ©ºê´Â º® µÎ²²¿Í »çÀÌ¡ÀÇ ±ÕÀϼºÀ» Çâ»ó½ÃÄÑ ·¹ÀÌÀú Àý´Ü °øÁ¤ÀÇ È¿À²¼ºÀ» ³ôÀ̰í, º¸´Ù »ç¿ëÇϱ⠽¬¿î ¹ßÆÇÀ» Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª¹ÙÀÌ·¯½º, ±×¸®°í °æ±âȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Biopharmaceutical tubing refers to specialized tubing used in the production and handling of biopharmaceutical products. It is engineered to meet rigorous standards for sterility, biocompatibility, and precision to ensure the safe and effective handling of sensitive materials throughout both manufacturing and administration processes.

The main products in the biopharmaceutical tubing market include silicone tubing, polyvinyl chloride (PVC) tubing, polyolefin tubing, and thermoplastic elastomer tubing. Silicone biopharmaceutical tubing is known for its flexibility and high purity, made from silicone rubber and specifically designed for use in the biopharmaceutical industry. Manufacturing processes for these tubes include extrusion and vulcanization, with applications spanning pharmaceuticals, medical devices, research and development, and other areas.

The biopharmaceutical tubing market research report is one of a series of new reports from The Business Research Company that provides biopharmaceutical tubing market statistics, including the biopharmaceutical tubing industry global market size, regional shares, competitors with biopharmaceutical tubing market share, detailed biopharmaceutical tubing market segments, market trends, and opportunities, and any further data you may need to thrive in the biopharmaceutical tubing industry. These biopharmaceutical tubing market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The biopharmaceutical tubing market size has grown rapidly in recent years. It will grow from $4.32 billion in 2024 to $4.82 billion in 2025 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to rise in demand for minimally invasive procedures, increase in elderly population, rise in demand for ultra- pure and corrosion- resistant system, and surge in demand for diagnostic equipment and drug delivery systems.

The biopharmaceutical tubing market size is expected to see rapid growth in the next few years. It will grow to $7.4 billion in 2029 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to increasing biopharmaceutical production, stricter regulation policies, rising need for efficient and contamination-free bioprocessing, rising safety measures, and growing pharmaceutical R&D. Major trends in the forecast period include advancements in single-use systems, innovations in tubing materials, advancements in customized tubing solutions, and innovation in tubing design.

The growing use of personalized medicines is expected to drive the expansion of the biopharmaceutical tubing market. Personalized medicine is an approach that customizes healthcare decisions, practices, interventions, and treatments to match the individual characteristics of each patient. This approach is gaining traction due to advancements in genetic research, which allow for treatment strategies tailored to an individual's genetic profile, lifestyle, and specific health conditions. Biopharmaceutical tubing plays a crucial role in personalized medicine by ensuring precise, sterile, and reliable fluid transfer, which is essential for delivering customized treatments and therapies. For instance, in 2022, the Personalized Medicine Coalition, a US-based membership organization, reported the approval of 12 new personalized medicines, representing about 34% of all newly approved therapies. This marks a significant increase compared to previous years, highlighting the role of personalized medicines in driving the growth of the biopharmaceutical tubing market.

Key players in the biopharmaceutical tubing market are advancing their product offerings with next-generation solutions, such as bioabsorbable tubing, to enhance performance, sterility, and fluid handling for advanced biopharmaceutical applications. Bioabsorbable tubing is made from materials that gradually break down and are absorbed by the body, eliminating the need for removal after use. For example, in September 2023, Zeus Company Inc., a US-based provider of advanced polymer solutions, introduced the Absorv XSE-oriented tubing, a next-generation bioabsorbable product designed for bioresorbable vascular scaffolds (BRS). This innovation allows medical device manufacturers to explore BRS applications beyond treating coronary artery disease and potentially replace metallic stents in various procedures. The new tubing offers improved wall thickness and sizing uniformity, enhancing efficiency during laser cutting processes and resulting in more usable scaffolds.

In February 2024, EQT Private Equity, a Sweden-based investment management firm, acquired Zeus Company Inc. for $3.4 billion. This acquisition aims to support Zeus's growth by investing in additional production capacity, research and development, and operational excellence, particularly in medical tubing technology. Zeus Company Inc. is a US-based manufacturer known for precision polymer extrusions and custom tubing.

Major companies operating in the biopharmaceutical tubing market are Compagnie de Saint-Gobain S.A., Thermo Fisher Scientific Inc., Merck KGaA, GE HealthCare Technologies Inc., Parker Hannifin Corporation, DuPont de Nemours Inc., Freudenberg Group, Medline Industries LP, Avantor Inc., Alfa Laval AB, REHAU Group, W. L. Gore & Associates Inc., Sartorius AG, Elkem ASA, Trelleborg AB, Bio-Rad Laboratories Inc., Tekni-Plex Inc., Pall Corporation, Zeus Company Inc., Watson-Marlow Ltd., Raumedic AG, Qosina, Optinova AB, ESI Ultrapure

North America was the largest region in the biopharmaceutical tubing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical tubing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biopharmaceutical tubing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biopharmaceutical tubing market consists of sales of polytetrafluoroethylene (PTFE) tubing, ethylene-vinyl acetate (EVA) tubing, and rubber tubing. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biopharmaceutical Tubing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biopharmaceutical tubing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for biopharmaceutical tubing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biopharmaceutical tubing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Biopharmaceutical Tubing Market Characteristics

3. Biopharmaceutical Tubing Market Trends And Strategies

4. Biopharmaceutical Tubing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Biopharmaceutical Tubing Growth Analysis And Strategic Analysis Framework

6. Biopharmaceutical Tubing Market Segmentation

7. Biopharmaceutical Tubing Market Regional And Country Analysis

8. Asia-Pacific Biopharmaceutical Tubing Market

9. China Biopharmaceutical Tubing Market

10. India Biopharmaceutical Tubing Market

11. Japan Biopharmaceutical Tubing Market

12. Australia Biopharmaceutical Tubing Market

13. Indonesia Biopharmaceutical Tubing Market

14. South Korea Biopharmaceutical Tubing Market

15. Western Europe Biopharmaceutical Tubing Market

16. UK Biopharmaceutical Tubing Market

17. Germany Biopharmaceutical Tubing Market

18. France Biopharmaceutical Tubing Market

19. Italy Biopharmaceutical Tubing Market

20. Spain Biopharmaceutical Tubing Market

21. Eastern Europe Biopharmaceutical Tubing Market

22. Russia Biopharmaceutical Tubing Market

23. North America Biopharmaceutical Tubing Market

24. USA Biopharmaceutical Tubing Market

25. Canada Biopharmaceutical Tubing Market

26. South America Biopharmaceutical Tubing Market

27. Brazil Biopharmaceutical Tubing Market

28. Middle East Biopharmaceutical Tubing Market

29. Africa Biopharmaceutical Tubing Market

30. Biopharmaceutical Tubing Market Competitive Landscape And Company Profiles

31. Biopharmaceutical Tubing Market Other Major And Innovative Companies

32. Global Biopharmaceutical Tubing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biopharmaceutical Tubing Market

34. Recent Developments In The Biopharmaceutical Tubing Market

35. Biopharmaceutical Tubing Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â